company science research partnership investor media contact

Proximagen announces positive efficacy results in NIH epilepsy studies Compulsory Acquisition of Outstanding Minster Shares Offer for Minster declared unconditional Strategic Update Recommended Cash Offer for Minster Pharmaceuticals Plc Completion of Acquisition of Cambridge Biotechnology Ltd Proximagen Acquires Cambridge Biotechnology Ltd Proximagen 2009 Interim Results Proximagen Raises £50M

2003-2010 copyright Proximagen Neuroscience plc. All rights reserved.